NCI, Inc. (NASDAQ:NCIT)‘s stock had its “buy” rating reiterated by investment analysts at Noble Financial in a research report issued on Wednesday.

Several other equities research analysts have also issued reports on NCIT. FBR & Co restated a “hold” rating and issued a $11.00 target price on shares of NCI in a report on Tuesday, April 4th. Zacks Investment Research lowered shares of NCI from a “hold” rating to a “sell” rating in a report on Saturday, April 8th. Cowen and Company reiterated a “buy” rating and set a $16.50 price objective on shares of NCI in a report on Monday, April 10th. Finally, ValuEngine upgraded shares of NCI from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $17.50.

NCI (NASDAQ NCIT) opened at 20.80 on Wednesday. The firm has a 50 day moving average of $17.92 and a 200-day moving average of $14.89. NCI has a 52-week low of $10.98 and a 52-week high of $21.00. The stock has a market cap of $281.86 million, a PE ratio of 46.53 and a beta of 0.98.

NCI (NASDAQ:NCIT) last released its earnings results on Tuesday, May 9th. The information technology services provider reported $0.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.21 by $0.04. The firm had revenue of $78.75 million during the quarter, compared to analyst estimates of $76.55 million. NCI had a net margin of 2.13% and a return on equity of 11.73%. Equities analysts anticipate that NCI will post $1.01 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “NCI, Inc. (NCIT) Rating Reiterated by Noble Financial” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/06/16/nci-inc-ncit-rating-reiterated-by-noble-financial.html.

A number of large investors have recently made changes to their positions in NCIT. Algert Global LLC raised its stake in shares of NCI by 10.8% in the first quarter. Algert Global LLC now owns 12,155 shares of the information technology services provider’s stock worth $183,000 after buying an additional 1,180 shares during the last quarter. Teachers Advisors LLC raised its stake in shares of NCI by 44.1% in the fourth quarter. Teachers Advisors LLC now owns 13,212 shares of the information technology services provider’s stock worth $184,000 after buying an additional 4,044 shares during the last quarter. Hancock Holding Co. bought a new stake in shares of NCI during the first quarter worth $189,000. Russell Investments Group Ltd. bought a new stake in shares of NCI during the fourth quarter worth $216,000. Finally, ClariVest Asset Management LLC raised its stake in shares of NCI by 5.3% in the first quarter. ClariVest Asset Management LLC now owns 14,464 shares of the information technology services provider’s stock worth $217,000 after buying an additional 727 shares during the last quarter. Institutional investors own 39.04% of the company’s stock.

NCI Company Profile

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

Receive News & Stock Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related stocks with our FREE daily email newsletter.